Cargando…

Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease

INTRODUCTION: Meniere’s disease (MD) is a disease of the inner ear that presents itself with repeated episodes of vertigo (96.2%), tinnitus (91.1%), and sensorineural hearing loss (87.7 %). In this article we sought to assess the effects of intratympanic (IT) injections of dexamethasone on definite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabiri Satri, Sasan, Gharibi, Reza, Nejadian, Farzaneh, Yazdani, Nasrin, Hoseinabadi, Reza, Rezazadeh, Nima, Firouzifar, Mohammad Reza, Babaei, Saeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448025/ https://www.ncbi.nlm.nih.gov/pubmed/28589104

Ejemplares similares

Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease
por: Masoumi, Elham, et al.
Publicado: (2017)

HLA-Cw Allele Frequency in Definite Meniere’s Disease Compared to Probable Meniere’s Disease and Healthy Controls in an Iranian Sample
por: Dabiri, Sasan, et al.
Publicado: (2016)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019)

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
por: Memari, Faramarz, et al.
Publicado: (2014)

Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)

Intratympanic corticosteroids for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Correction: Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
Publicado: (2014)

Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy
por: Molnár, András, et al.
Publicado: (2021)

Consensus on intratympanic drug delivery for Menière’s disease
por: Li, Shuna, et al.
Publicado: (2022)

Editorial: Intratympanic and surgical treatment for Meniere's disease
por: Yang, Jun, et al.
Publicado: (2022)

Intratympanic corticosteroids in Ménière's disease: A mini-review
por: Patel, Mitesh
Publicado: (2017)

Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
por: Guan, Yafeng, et al.
Publicado: (2021)

Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020)

Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022)

The Effect of Intratympanic Dexamethasone with Oral Prednisolone as a Primary Treatment in Idiopathic Sudden Sensorineural Hearing Loss
por: Khorsandi Ashtiani, Mohammad Taghi, et al.
Publicado: (2012)

Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial
por: Lambert, Paul R., et al.
Publicado: (2016)

Effects of an Intratympanic Injection of Dexamethasone Combined with Gentamicin on the Expression Level of Serum P0 Protein Antibodies in Patients with Meniere’s Disease
por: Geng, Yang, et al.
Publicado: (2020)

Systemic effects of intratympanic dexamethasone therapy
por: Novoa, Eva, et al.
Publicado: (2014)

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018)

MRI With Intratympanic Gadolinium: Comparison Between Otoneurological and Radiological Investigation in Menière's Disease
por: Neri, Giampiero, et al.
Publicado: (2021)

Electrocochleographic recording in Asian adults: Preliminary normative data and demographic analyses
por: Zakaria, Mohd Normani, et al.
Publicado: (2017)

Evaluation of the Correlation between CD44, Tumor Prognosis and the 5-Year Survival Rate in Patients with Oral Tongue SCC
por: Kaboodkhani, Reza, et al.
Publicado: (2016)

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone
por: Le, Thi Phuc, et al.
Publicado: (2023)

The Effect of Intracochlear and Intratympanic Dexamethasone on Cochlear Implant Impedance
por: Ardıç, Fazıl Necdet, et al.
Publicado: (2023)

Intratympanic Dexamethasone Role in Hearing Protection in Cancer Patients
por: Gupta, Dipti, et al.
Publicado: (2023)

The Effects of the Vestibular Rehabilitation on the Benign Paroxysmal Positional Vertigo Recurrence Rate in Patients with Otolith Dysfunction
por: Hoseinabadi, Reza, et al.
Publicado: (2018)

Intraoperative Electrocochleographic Characteristics of Auditory Neuropathy Spectrum Disorder in Cochlear Implant Subjects
por: Riggs, William J., et al.
Publicado: (2017)

Cranial nerve palsy prevalence and associated factors in patients with malignant otitis externa
por: Zonnour, Alireza, et al.
Publicado: (2023)

One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings
por: Daneshi, Ahmad, et al.
Publicado: (2014)

Use of Skull Vibration-Induced Nystagmus in the Follow-up of Patients With Ménière Disease Treated With Intratympanic Gentamicin
por: Alonso, Susana Marcos, et al.
Publicado: (2023)

Intratympanic dexamethasone for managing pregnant women with sudden hearing loss
por: Fu, Yaoyao, et al.
Publicado: (2018)

Intratympanic dexamethasone injection for sudden sensorineural hearing loss in pregnancy
por: Lyu, Yan-Lu, et al.
Publicado: (2020)

Clinical Analysis of Intratympanic Injection of Dexamethasone for Treating Sudden Deafness
por: Li, Xin, et al.
Publicado: (2021)

Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature
por: Walther, L. E., et al.
Publicado: (2013)

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss
por: Jung, So-Young, et al.
Publicado: (2021)

Dexamethasone does not affect endolymphatic hydrops (EH) in patients with Meniere's disease within 24 h, and intratympanic administration of gadolinium plus dexamethasone simplifies high-quality imaging of EH using a novel protocol of 7 min()
por: Zou, Jing, et al.
Publicado: (2022)

Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease
por: Fukuoka, Hisakuni, et al.
Publicado: (2012)

Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study
por: Liu, Bo, et al.
Publicado: (2016)

Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies
por: Phillips, John, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ng4trs8aldviqftda6cf916i3s